WHO guidelines on tuberculosis infection prevention and control: 2019 update
The revised guidelines includes recommendations for specific administrative controls, environmental controls, and respiratory protection controls.
TB
Back to Results
See-and-Touch Artificial Arms With Mantoux TB Skin Reaction
The tool shows sample reactions to the Mantoux tuberculin skin test and includes a card with descriptions of each reaction. The product is $330, which includes one arm, one base, and shipping.
Total cost of $330 includes one arm, one base, and shipping. Also included is a laminated card that provides full descriptions of each reaction.
Available in light, medium, and dark skin tone please make a skin tone selection before you add this item to your cart.
Mantoux Tuberculin Skin Testing Rulers
Rulers made of a thin, and wipeable PVC material for measuring skin test reactions from the Mantoux tuberculin skin test. The rulers are available for order in quantities of 25 or 100.
CDC’s Molecular Detection of Drug Resistance Service: Rapid Test Results for Real-Time Patient Care
The infographic provides information on the importance of CDC's Molecular Detection of Drug Resistance (MDDR) service, how drug resistance develops, and how CDC assists TB programs. The infographic also includes a case study.
Under the Microscope: A Closer Look at CDC’s Tuberculosis Laboratory
The infographic explains how the CDC's TB laboratory supports health departments, shares the laboratory's mission, details laboratory partnerships, and more.
Coping with TB in the time of COVID-19
This slide set provides key information on TB and COVID-19 co-infection.
Reported Tuberculosis in the United States, 2019
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2019.
To End TB - Prevent Tuberculosis
This video encourages young children and household contacts of TB patients to adhere to TB treatment to help prevent TB.
How to Protect Ourselves from TB - About TB Preventive Treatment
The resource includes information on TB preventive treatment, including who needs TB preventive treatment, treatment options, and frequently asked questions for people living with HIV.
NTCA Provider Guidance: Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)
The resource was designed to help healthcare providers:
1. Quickly identify and answer key questions when considering whether to start a patient on the isoniazid-rifapentine (3HP) regimen
2. Assess the appropriateness of self-administered therapy of 3HP for each individual patient
3. Ensure that the correct drugs for the 3HP regimen are prescribed and provided to the patient
4. Handle questions on side effects and adverse reactions for a patient currently on the 3HP regimen